113 related articles for article (PubMed ID: 37615374)
1. Methylprednisolone use in children with severe pneumonia caused by severe acute respiratory syndrome coronavirus 2.
Ozsurekci Y; Aykac K; Demir OO; Ilbay S; Kesici S; Karakaya J; Cengiz AB
Pediatr Int; 2023; 65(1):e15603. PubMed ID: 37615374
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis.
Wu C; Hou D; Du C; Cai Y; Zheng J; Xu J; Chen X; Chen C; Hu X; Zhang Y; Song J; Wang L; Chao YC; Feng Y; Xiong W; Chen D; Zhong M; Hu J; Jiang J; Bai C; Zhou X; Xu J; Song Y; Gong F
Crit Care; 2020 Nov; 24(1):643. PubMed ID: 33172477
[TBL] [Abstract][Full Text] [Related]
3. High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study.
Monreal E; Sainz de la Maza S; Natera-Villalba E; Beltrán-Corbellini Á; Rodríguez-Jorge F; Fernández-Velasco JI; Walo-Delgado P; Muriel A; Zamora J; Alonso-Canovas A; Fortún J; Manzano L; Montero-Errasquín B; Costa-Frossard L; Masjuan J; Villar LM;
Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):761-769. PubMed ID: 33083917
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia.
Pinzón MA; Ortiz S; Holguín H; Betancur JF; Cardona Arango D; Laniado H; Arias Arias C; Muñoz B; Quiceno J; Jaramillo D; Ramirez Z
PLoS One; 2021; 16(5):e0252057. PubMed ID: 34033648
[TBL] [Abstract][Full Text] [Related]
5. Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study.
Bozzi G; Mangioni D; Minoia F; Aliberti S; Grasselli G; Barbetta L; Castelli V; Palomba E; Alagna L; Lombardi A; Ungaro R; Agostoni C; Baldini M; Blasi F; Cesari M; Costantino G; Fracanzani AL; Montano N; Monzani V; Pesenti A; Peyvandi F; Sottocorno M; Muscatello A; Filocamo G; Gori A; Bandera A
J Allergy Clin Immunol; 2021 Feb; 147(2):561-566.e4. PubMed ID: 33220354
[TBL] [Abstract][Full Text] [Related]
6. Methylprednisolone in severe COVID-19 with acute respiratory distress syndrome - less is more?
Ngu NH; Chai CS; Chan SK; Kho SS; Yong MC; Tie ST
Med J Malaysia; 2022 Nov; 77(6):650-654. PubMed ID: 36448380
[TBL] [Abstract][Full Text] [Related]
7. Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients.
Saeed MAM; Mohamed AH; Owaynat AH
Egypt J Intern Med; 2022; 34(1):19. PubMed ID: 35194371
[TBL] [Abstract][Full Text] [Related]
8. Role of the early short-course corticosteroids treatment in ARDS caused by COVID-19: A single-center, retrospective analysis.
Boglione L; Olivieri C; Rostagno R; Poletti F; Moglia R; Bianchi B; Esposito M; Biffi S; Borrè S
Adv Med Sci; 2021 Sep; 66(2):262-268. PubMed ID: 34022675
[TBL] [Abstract][Full Text] [Related]
9. The Use of High-Dose Corticosteroids Versus Low-Dose Corticosteroids With and Without Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome.
Katz A; Altshuler D; Papadopoulos J; Amoroso N; Goldenberg R; Tarras E; Krolikowski K; Hagedorn J; Fridman D; Chen XJC; Iturrate E; Brosnahan SB
Ann Pharmacother; 2023 Jan; 57(1):5-15. PubMed ID: 35590468
[TBL] [Abstract][Full Text] [Related]
10. A Case Report for Using Methylprednisolone for Severe ARDS Caused by SARS-CoV-2 Delta Variant in a Pediatric Patient With Lennox-Gastaut Syndrome.
Park E; You J
J Korean Med Sci; 2022 Mar; 37(10):e82. PubMed ID: 35289141
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome.
Liu J; Zhang S; Dong X; Li Z; Xu Q; Feng H; Cai J; Huang S; Guo J; Zhang L; Chen Y; Zhu W; Du H; Liu Y; Wang T; Chen L; Wen Z; Annane D; Qu J; Chen D
J Clin Invest; 2020 Dec; 130(12):6417-6428. PubMed ID: 33141117
[TBL] [Abstract][Full Text] [Related]
12. Effect of pulse methylprednisolone on prognosis in SARS-CoV-2 patients with severe pneumonia.
Eraslan BZ; Fidan A; Baysal T; Cömert SS; Kıral N; Parmaksız ET
Eur Rev Med Pharmacol Sci; 2024 Feb; 28(3):1234-1240. PubMed ID: 38375729
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy of equivalent doses of dexamethasone, methylprednisolone, and hydrocortisone for treatment of COVID-19-related acute respiratory distress syndrome: a prospective three-arm randomized clinical trial.
Taher A; Lashkari M; Keramat F; Hashemi SH; Sedighi L; Poorolajal J; Mehrpooya M
Wien Med Wochenschr; 2023 Apr; 173(5-6):140-151. PubMed ID: 36624180
[TBL] [Abstract][Full Text] [Related]
14. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
15. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
16. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
[TBL] [Abstract][Full Text] [Related]
17. High-Dose Steroids for Nonresolving Acute Respiratory Distress Syndrome in Critically Ill COVID-19 Patients Treated With Dexamethasone: A Multicenter Cohort Study.
Lopinto J; Arrestier R; Peiffer B; Gaillet A; Voiriot G; Urbina T; Luyt CE; Bellaïche R; Pham T; Ait-Hamou Z; Roux D; Clere-Jehl R; Azoulay E; Gaudry S; Mayaux J; Mekontso Dessap A; Canoui-Poitrine F; de Prost N
Crit Care Med; 2023 Oct; 51(10):1306-1317. PubMed ID: 37199534
[TBL] [Abstract][Full Text] [Related]
18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
19. Comparison of pulse-dose and high-dose corticosteroids with no corticosteroid treatment for COVID-19 pneumonia in the intensive care unit.
Yaqoob H; Greenberg D; Hwang F; Lee C; Vernik D; Manglani R; Wang Z; Murad MH; Chandy D; Epelbaum O
J Med Virol; 2022 Jan; 94(1):349-356. PubMed ID: 34542192
[TBL] [Abstract][Full Text] [Related]
20. Association of Serum Ferritin Levels and Methylprednisolone Treatment With Outcomes in Nonintubated Patients With Severe COVID-19 Pneumonia.
Papamanoli A; Kalogeropoulos AP; Hotelling J; Yoo J; Grewal P; Predun W; Jacob RP; Cao K; Marcos LA; Skopicki HA
JAMA Netw Open; 2021 Oct; 4(10):e2127172. PubMed ID: 34605919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
